Physician profile
Tauseef Akhtar
NPI 1508218009
$7,654.65
in general payments reported to CMS, 2019-2025
21 companies · $4,918 in 2025
The $4,918 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $441 · 2023: $858 · 2024: $1,438 · 2025: $4,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,390 · Food and Beverage: $2,849 · Education: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,390.38 |
| Food and Beverage | $2,849.48 |
| Education | $973.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,159.94 | 2022-2025 | Gallant, Cardiomems, Ensite |
| Medtronic, INC. | $959.42 | 2024-2025 | Corevalve Evolut R, Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $532.77 | 2022-2025 | Brilinta, Wainua, Andexxa |
| Boston Scientific Corporation | $276.72 | 2025 | General - Vascular Access, Versacross Access Solution |
| Shockwave Medical, INC | $274.99 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $267.84 | 2022-2024 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.76 | 2022-2025 | Lifevest |
| Abiomed | $216.65 | 2025 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $97.48 | 2023-2025 | Camzyos |
| Janssen Scientific Affairs, LLC | $78.85 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.96 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $72.23 | 2023-2024 | |
| Teleflex LLC | $65.16 | 2023 | Trapliner |
| Getinge USA Sales, LLC | $47.70 | 2024-2025 | Cardiosave Rescue, Cardiohelp |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $42.20 | 2023 | Verquvo |
| Biosense Webster, INC. | $23.76 | 2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $19.36 | 2023 | Xarelto |
| Cook Medical LLC | $15.29 | 2023 | Beacon Tip Torcon Nb |
| Asahi Intecc USA, INC. | $14.74 | 2025 | Asahi Peripheral Vascular Wires |
| Terumo Medical Corporation | $13.83 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tauseef Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.